Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Attitudes toward genetic testing, family planning and preimplantation genetic testing in families with a germline CDKN2A pathogenic variant.

Familial cancer - 1 Aug 2024

Onnekink A M, Klatte D C F, van Hooft J E, van den Berg S H, van der Zwaan S M S, van Doorn R, Hinnen S C H, Potjer T P, Bleiker E M A, van Leerdam M E

Abstract excerpt

Individuals with a germline CDKN2A pathogenic variant (PV) have a highly increased life time risk of melanoma and pancreatic cancer. This cross-sectional study assessed the attitudes among toward genetic testing, family planning, and preimplantation genetic testing (PGT) in confirmed CDKN2A PV carriers and individuals with a 50% risk of the PV (at-risk carriers) using of a one-time questionnaire.A total of 537...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cyclin-Dependent Kinase Inhibitor p16
Share to Cyclin-Dependent Kinase Inhibitor p18

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Germ-Line Mutation

Share to Health Knowledge, Attitudes, Practice

Share to Melanoma

Share to Pancreatic Neoplasms

Share to Preimplantation Diagnosis

Share to Surveys and Questionnaires

Source

Open in PubMed Open full text

Identifiers

PMID: 38822936
DOI: 10.1007/s10689-024-00401-3
PMCID: PMC11255069

Genes

CDKN2A

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Attitudes toward genetic testing, family planning and preimplantation genetic testing in families with a germline CDKN2A pathogenic variant.PMID 38822936Read ↗

Psychosocial issues of individuals undergoing surveillance for increased risk of melanoma and pancreatic cancer due to a germline CDKN2A variant: A focus group study.Semantic proximity Read ↗

Considerations for Germline Testing in Melanoma: Updates in Behavioral Change and Pancreatic Surveillance for Carriers of CDKN2A Pathogenic VariantsSemantic proximity Read ↗

"Would you test your children without their consent?" and other sticky dilemmas in the field of cancer genetic testing.Semantic proximity Read ↗

Reproductive Choices and Attitudes Toward Preimplantation Genetic Testing Among Individuals with Hereditary Cancer PredispositionSemantic proximity Read ↗

Attitudes toward genetic testing in childhood and reproductive decision-making for familial adenomatous polyposisSemantic proximity Read ↗

Parental preferences for CDKN2A/p16 testing of minors.Semantic proximity Read ↗

Comparing family members’ motivations and attitudes towards genetic testing for hereditary breast and ovarian cancer: a qualitative analysisSemantic proximity Read ↗

Ethical and Psychosocial Issues Associated with Genetic Testing for Hereditary Tumor Predisposition SyndromesSemantic proximity Read ↗

Genetic testing for hereditary melanoma and pancreatic cancer: a longitudinal study of psychological outcome.Semantic proximity Read ↗

Family planning in carriers of BRCA1 and BRCA2 pathogenic variants.Semantic proximity Read ↗

The Knowledge and Attitude of Patients Diagnosed with Epithelial Ovarian Cancer towards Genetic Testing.Semantic proximity Read ↗

Differences in attitudes toward genetic testing among the public, patients, and health-care professionals in Korea.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.